World's most expensive drug brings in $186M for Novartis in Q4

Listen

Zolgensma, the world's most expensive drug, brought in $186 million for Novartis in the fourth quarter, beating analysts expectations, STAT reported. 

The one-time gene therapy treatment is priced at $2.1 million and is designed to treat spinal muscular atrophy in infants. 

Novartis said about 200 patients have been treated with Zolgensma since it launched last June, according to STAT

The drug is covered for 97 percent of patients with commercial plans; 50 percent of Medicaid patients are covered.

Read the full article here

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars